VivoSim Labs shares jump 11.89% intraday after pricing $4 million public offering to raise capital amid cash burn concerns.

VivoSim Labs surged 11.89% intraday following the announcement of a $4 million public offering priced at $1.14 per share. The capital raise, led by a New York-based family office, includes an initial $3 million closing with the issuance of common shares, pre-funded warrants, and additional common warrants. The offering represents a significant infusion for the company, which has a market cap of just $3.72 million and has declined sharply over the past six months. The stock’s strong intraday rally suggests investor optimism about the near-term liquidity boost and the company’s efforts to strengthen its leadership and scientific capabilities through recent executive appointments and model validations.